Part D Perspectives: Women Against Prostate Cancer

Part D Perspectives: Women Against Prostate Cancer

11.20.12 | By

Below is the latest guest post in our "Part D Perspectives" series, which we'll be hosting during the 2013 Medicare Part D Open Enrollment Period (Oct. 12 - Dec. 7).

Theresa Morrow, co-founder of Women Against Prostate Cancer, shares her views on the importance of Part D and how it helps prostate cancer sufferers:

Women Against Prostate Cancer (WAPC) is a national organization that supports the millions of women whose loved ones have been affected by prostate cancer and their families. This is a very compassionate group, and we work with these women regularly to advocate for a variety of prostate cancer related issues.

One of our most important goals is ensuring access to the health care services and treatments needed to maintain and improve the health of men suffering from prostate cancer, and their families. Medicare Part D is one program that helps us meet that goal by providing quality prescription drug coverage at an affordable price.

During the open enrollment period, men and women are offered valuable time each year to compare prescription drug plans and ensure their plan fits their ever-changing health and financial needs. It is an especially important tool for the wives, sisters, friends and family who often serve as an essential caregiver to make these important decisions for their loved ones.

Prostate cancer is a devastating disease. Aside from non-melanoma skin cancer, it is the most common cancer in the U.S. with more than 214,000 men diagnosed in 2008, according to the CDC. The successful management and treatment of this disease requires individuals to have consistent access to the effective drugs on the schedule prescribed by their physician. A recent Medicare Today study indicated that without Part D, six out of 10 seniors would not be able to fill all of their prescriptions, leading them to cut back or stop taking certain medicines altogether.

Since Part D provides those essential medicines at an affordable price, patients can better adhere to their treatment plans and improve their health. And, they are improving the health of our economy as well. Under-treating diseases due to non-adherence costs the U.S. economy hundreds of billions of dollars each year. By better enabling patients to adhere to their medications, Part D is improving the lives of millions of Americans suffering from devastating diseases and contributing to the long-term health of our nation.

More On PhRMA — powered by PhRMApedia


Cost in Context